Theriva Biologics Inc (TOVX)
1.35
-0.07
(-4.93%)
USD |
NYAM |
Nov 14, 16:00
1.365
+0.02
(+1.11%)
After-Hours: 20:00
Theriva Biologics Cash and Short Term Investments (Quarterly): 16.59M for June 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 16.59M |
| March 31, 2024 | 18.26M |
| December 31, 2023 | 23.18M |
| September 30, 2023 | 31.16M |
| June 30, 2023 | 34.25M |
| March 31, 2023 | 36.08M |
| December 31, 2022 | 41.79M |
| September 30, 2022 | 50.49M |
| June 30, 2022 | 52.27M |
| March 31, 2022 | 56.69M |
| December 31, 2021 | 67.32M |
| September 30, 2021 | 72.14M |
| June 30, 2021 | 74.29M |
| March 31, 2021 | 76.89M |
| December 31, 2020 | 6.227M |
| September 30, 2020 | 6.005M |
| June 30, 2020 | 8.059M |
| March 31, 2020 | 10.08M |
| December 31, 2019 | 15.04M |
| September 30, 2019 | 18.65M |
| June 30, 2019 | 21.71M |
| March 31, 2019 | 24.69M |
| December 31, 2018 | 28.92M |
| September 30, 2018 | 9.549M |
| June 30, 2018 | 7.129M |
| Date | Value |
|---|---|
| March 31, 2018 | 11.04M |
| December 31, 2017 | 17.12M |
| September 30, 2017 | 21.05M |
| June 30, 2017 | 13.38M |
| March 31, 2017 | 13.47M |
| December 31, 2016 | 19.06M |
| September 30, 2016 | 4.549M |
| June 30, 2016 | 10.05M |
| March 31, 2016 | 15.10M |
| December 31, 2015 | 20.82M |
| September 30, 2015 | 31.81M |
| June 30, 2015 | 4.757M |
| March 31, 2015 | 12.05M |
| December 31, 2014 | 17.52M |
| September 30, 2014 | 3.286M |
| June 30, 2014 | 7.843M |
| March 31, 2014 | 11.16M |
| December 31, 2013 | 14.62M |
| September 30, 2013 | 5.145M |
| June 30, 2013 | 6.877M |
| March 31, 2013 | 8.52M |
| December 31, 2012 | 9.954M |
| September 30, 2012 | 4.577M |
| June 30, 2012 | 5.932M |
| March 31, 2012 | 6.802M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
6.005M
Minimum
Sep 2020
76.89M
Maximum
Mar 2021
36.67M
Average
34.25M
Median
Jun 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| Merck & Co Inc | 14.59B |
| Pro-Dex Inc | 7.819M |
| BioCardia Inc | 1.421M |
| NovaBay Pharmaceuticals Inc | 0.776M |
| Palatin Technologies Inc | 9.527M |